D.E. Shaw & Co’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-150,695
| Closed | -$357K | – | 3492 |
|
|
2023
Q4 | $357K | Buy |
150,695
+94,885
| +170% | +$225K | ﹤0.01% | 2505 |
|
|
2023
Q3 | $78.1K | Sell |
55,810
-4,299
| -7% | -$6.02K | ﹤0.01% | 2693 |
|
|
2023
Q2 | $182K | Buy |
+60,109
| New | +$182K | ﹤0.01% | 2626 |
|
|
2022
Q1 | – | Sell |
-13,989
| Closed | -$248K | – | 4577 |
|
|
2021
Q4 | $248K | Sell |
13,989
-14,479
| -51% | -$257K | ﹤0.01% | 3397 |
|
|
2021
Q3 | $655K | Buy |
28,468
+7,711
| +37% | +$177K | ﹤0.01% | 2706 |
|
|
2021
Q2 | $483K | Sell |
20,757
-2,088
| -9% | -$48.6K | ﹤0.01% | 2905 |
|
|
2021
Q1 | $712K | Buy |
+22,845
| New | +$712K | ﹤0.01% | 2349 |
|